Sun Pharma shares gained after a U.S. court lifted an injunction, clearing the way for the launch of LEQSELVI, its drug for autoimmune-related hair loss. The legal battle with Incyte continues, but ...

Shares of India-focused Mankind Pharma Ltd, Alkem Laboratories Ltd, Abbott India Ltd and JB Chemicals & Pharmaceuticals Ltd have fallen only 3-5% since the reciprocal tariffs were announced.

Mankind Pharma continued to make significant strides in market positioning with consistent double-digit growth, reflecting strong brand traction across both chronic and acute therapies. Glenmark and ...

16:01 EDT Vincerx Pharma (VINC) Inc trading halted, news pending Discover outperforming stocks and invest smarter with Top Smart Score Stocks. Filter, analyze, and streamline your search for ...

New Delhi: In a major relief to Mankind Pharma Limited, the Delhi High Court has directed the removal of the trademark KINDPAN from the Register of Trade Marks, holding that it infringed upon the well ...

The Delhi High Court has directed the removal of 'Kindpan' trademark, in a petition filed by Mankind Pharma Limited against a proprietorship firm which was granted registration of the mark in the ...

If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 12.5%, if your total long term capital gain exceeds 1.25 lakh. Any cess/surcharge is not ...

If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 12.5%, if your total long term capital gain exceeds 1.25 lakh. Any cess/surcharge is not ...

Mankind Pharma has successfully amalgamated its three subsidiaries, namely, Shree Jee Laboratory Pvt. Ltd., JPR Labs Pvt. Ltd. and Jaspack Industries Pvt. Ltd into the company. The merger took ...

Mankind Pharma has officially completed the amalgamation of three of its subsidiaries—Shree Jee Laboratory Private Limited, JPR Labs Private Limited, and Jaspack Industries Private Limited—into the ...

Mankind Pharma has received tax demand orders from the Income Tax Department for Assessment Years (AY) 2014-15 to 2017-18, amounting to ₹183.11 crore, including interest. The demand arises from the ...

Intimation under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015 ...